3,473
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

A Japanese nationwide survey of 23-valent pneumococcal capsular polysaccharide vaccine (PPSV23) coverage among patients with chronic medical condition aged 50 and older

, , , &
Pages 1521-1528 | Received 02 Sep 2019, Accepted 04 Nov 2019, Published online: 04 Dec 2019

References

  • World Health Organization. 23-valent pneumococcal polysaccharide vaccine. WHO position paper. Wkly Epidemiol Rec. 2008;83(42):373–84. PMID:1892997.
  • Drijkoningen JJ, Rohde GG. Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect. 2014;20 Suppl 5:45–51. PMID:24313448. doi:10.1111/1469-0691.12461.
  • Miyashita N, Matsushima T, Oka M, Japanese Respiratory S. The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. Intern Med. 2006;45(7):419–28. PMID:16679695. doi:10.2169/internalmedicine.45.1691.
  • Kyaw MH, Rose CE Jr., Fry AM, Singleton JA, Moore Z, Zell ER, Whitney CG; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis. 2005;192(3):377–86. PMID:15995950. doi:10.1086/431521.
  • Ishiguro T, Kagiyama N, Uozumi R, Odashima K, Kurashima K, Morita S, Takayanagi N. Risk factors for the severity and mortality of pneumococcal pneumonia: importance of premorbid patients’ performance status. J Infect Chemother. 2016;22(10):685–91. PMID:27593263. doi:10.1016/j.jiac.2016.07.008.
  • Ministry of health, labour and welfare. Pneumococcal infection (elderly person) [accessed 2019 Sep 2]. http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/kekkaku-kansenshou/haienkyukin/index_1.html.
  • Feldman C, Anderson R. Epidemiology, virulence factors and management of the pneumococcus. F1000Res. 2016;5:2320. PMID:27703671. doi:10.12688/f1000research.9283.1.
  • German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute. Recommendations of the standing committee on vaccination (STIKO) at the Robert Koch institute/effective. 2016 Aug. doi:10.17886/EpiBull-2016-072.
  • Petigara T, Zhang D. Pneumococcal vaccine coverage in adults aged 19–64 years, newly diagnosed with chronic conditions in the U.S. Am J Prev Med. 2018;54(5):630–36. PMID:29551328. doi:10.1016/j.amepre.2018.01.033.
  • Vila-Corcoles A, Ochoa-Gondar O, Hospital I, de Diego C, Satué E, Bladé J, Ansa X, Guzmán JA, Salsench E, Ramos F. Pneumococcal vaccination coverages among low-, intermediate-, and high-risk adults in Catalonia. Hum Vaccin Immunother. 2016;12(11):2953–58. PMID:27454779. doi:10.1080/21645515.2016.1210744.
  • Yang TU, Song JY, Noh JY, Cheong HJ, Kim WJ. Influenza and pneumococcal vaccine coverage rates among patients admitted to a teaching hospital in South Korea. Infect Chemother. 2015;47(1):41–48. PMID:25844262. doi:10.3947/ic.2015.47.1.41.
  • Imai K, Petigara T, Kohn MA, Nakashima K, Aoshima M, Shito A, Kanazu S. Risk of pneumococcal diseases in adults with underlying medical conditions: a retrospective, cohort study using two Japanese healthcare databases. BMJ Open. 2018;8(3):e018553. PMID:29500201. doi:10.1136/bmjopen-2017-018553.
  • Fukusumi M, Chang B, Tanabe Y, Oshima K, Maruyama T, Watanabe H, Kuronuma K, Kasahara K, Takeda H, Nishi J, et al. Invasive pneumococcal disease among adults in Japan, April 2013 to March 2015: disease characteristics and serotype distribution. BMC Infect Dis. 2017;17(1):2. PMID:28049447. doi:10.1186/s12879-016-2113-y.
  • Ubukata K, Takata M, Morozumi M, Chiba N, Wajima T, Hanada S, Shouji M, Sakuma M, Iwata S; Invasive Pneumococcal Diseases Surveillance Study Group. Effects of pneumococcal conjugate vaccine on genotypic penicillin resistance and serotype changes, Japan, 2010–2017. Emerg Infect Dis. 2018;24(11):2010–20. PMID:30334707. doi:10.3201/eid2411.180326.
  • Kim DK, Riley LE, Harriman KH, Hunter P, Bridges CB; Advisory Committee on Immunization P. Recommended immunization schedule for adults aged 19 years or older, United States, 2017. Ann Intern Med. 2017;166(3):209–19. PMID:28166560. doi:10.7326/M16-2936.
  • The Japanese Respiratory Society (JRS). Guidelines for the management of pneumonia in adults. 2017 [accessed 2019 Sep 2]. http://www.jrs.or.jp/modules/guidelines/index.php?content_id=94.
  • Japanese Diabetes Society. Japanese clinical practice guideline for diabetes 2016 [accessed 2019 Sep 2]. http://www.jds.or.jp/modules/publication/index.php?content_id=4.
  • Sakamoto A, Chanyasanha C, Sujirarat D, Matsumoto N, Nakazato M. Factors associated with pneumococcal vaccination in elderly people: a cross-sectional study among elderly club members in Miyakonojo City, Japan. BMC Public Health. 2018;18(1):1172. PMID:30314498. doi:10.1186/s12889-018-6080-7.
  • Higuchi M, Narumoto K, Goto T, Inoue M. Correlation between family physician’s direct advice and pneumococcal vaccination intention and behavior among the elderly in Japan: a cross-sectional study. BMC Fam Pract. 2018;19(1):153. PMID:30185157. doi:10.1186/s12875-018-0841-3.
  • Carreno-Ibanez LV, Esteban-Vasallo MD, Dominguez-Berjon MF, Astray-Mochales J, González Del Yerro C, Iniesta-Fornies D, Gascón-Sancho MJ, Jiménez-García R. Coverage of and factors associated with pneumococcal vaccination in chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2015;19(6):735–41. PMID:25946369. doi:10.5588/ijtld.14.0480.
  • Hanada S, Iwata S, Kishi K, Morozumi M, Chiba N, Wajima T, Takata M, Ubukata K; Invasive Pneumococcal Diseases Surveillance Study Group. Host factors and biomarkers associated with poor outcomes in adults with invasive pneumococcal disease. PLoS One. 2016;11(1):e0147877. PMID:26815915. doi:10.1371/journal.pone.0147877.
  • Ministry of health, labour and welfare. Number of vaccinated in national immunization schedule [accessed 2019 Sep 2]. https://www.mhlw.go.jp/topics/bcg/other/5.html.